Category Archives: Pr Newswire

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) — Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) advising that, because […]

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that on August 22, 2024, the Company received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company […]

Cingulate Announces Adjournment of Special Meeting

KANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ:CING), (“Cingulate” or the “Company”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that it has adjourned its Special Meeting of Stockholders (the “Special Meeting”) in […]

China Liberal Education Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

BEIJING, Aug. 24, 2024 /PRNewswire/ — China Liberal Education Holdings Limited (Nasdaq: CLEU) (“China Liberal”, the “Company”, “we”, “our”, or “us”), a China-based company that provides smart campus solutions and other educational services, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 21, 2024, notifying the […]

REALTY ONE GROUP INTERNATIONAL SOARS PAST 20K REAL ESTATE PROFESSIONALS AROUND THE WORLD

Real Estate’s UNBrokerage Thrives on 100% Commission Model and Bold,Dynamic COOLTURE to Attract Raving Fans in the U.S. and 20 Countries LAGUNA NIGUEL, Calif., Aug. 24, 2024 /PRNewswire/ — Realty ONE Group International, a modern, purpose-driven lifestyle brand and ONE of the fastest-growing franchisors in the world, just surpassed 20,000 real estate professionals worldwide as the […]

Hisense and Black Myth: Wukong Redefine the Standard for 3A Gaming Experiences on Large Screens

QINGDAO, China, Aug. 24, 2024 /PRNewswire/ — The launch of the highly anticipated Black Myth: Wukong marked a step change in the gaming industry. China’s landmark AAA game, paired with Hisense’s exceptional display capabilities, offers a visually stunning journey through the rich tapestry of Chinese storytelling. Join a global community of gamers and discover the timeless […]

WiMi Hologram Cloud Announced an Identity Management Model Based on Blockchain

BEIJING, Aug. 23, 2024 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that its R&D team delved into the application potential of blockchain in the field of identity management. The decentralized nature of blockchain as an open distributed ledger offers the […]

CStone Reports 2024 Interim Results and Recent Corporate Updates

Total revenue of RMB 254.2 million for 2024 H1; achieving first-time profitability with cash reserve at RMB 814 million as of June 30, 2024. NDA approval of sugemalimab (PD-L1) for Stage IV NSCLC in EU, marking the first successful international approval of a China domestic anti-PD-L1 mAb. Partnered with Ewopharma for sugemalimab commercialization in Central […]

WORK Medical Technology Group LTD Announces Pricing of Initial Public Offering

Hangzhou, China, Aug. 23, 2024 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (the “Company”), a supplier of medical devices in China, today announced the pricing of the initial public offering (the “Offering”) of its 2,000,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for […]

Repligen Corporation to Present at Wells Fargo Healthcare Conference

WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the Wells Fargo Healthcare Conference being held September 4-6 in Boston. Olivier Loeillot, President and Chief Executive Officer will participate in an analyst-led discussion on Friday, September […]